{
  "zip": "75008",
  "sector": "Healthcare",
  "fullTimeEmployees": 100409,
  "longBusinessSummary": "Sanofi provides therapeutic solutions worldwide. It offers Cerezyme and Cerdelga for Gaucher, Myozyme and Lumizyme for Pompe, Fabrazyme for Fabry, and Aldurazyme for mucopolysaccharidosis Type 1; and Aubagio and Lemtrada for multiple sclerosis. It also provides Dupixent for atopic dermatitis; Kevzara for rheumatoid arthritis; Eloctate and Alprolix to treat hemophilia; and Cablivi to treat acquired thrombotic thrombocytopenic purpura. In addition, it offers Libtayo for metastatic cutaneous squamous cell carcinoma; Jevtana and Taxotere taxane for cancers; Eloxatin for colon cancer; Thymoglobulin, an immunosuppressive and immunomodulating agent; Mozobil for hematologic malignancies; and Zaltrap for metastatic colorectal cancer. Further, it provides Lantus, Toujeo, Apidra, and Insuman insulins; Amaryl sulfonylurea; Adlyxin/Lyxumia, a GLP-1 receptor agonist; Soliqua 100/33/Suliqua, an insulin glargine and lixisenatide combination to treat diabetes; Admelog/Insulin lispro insulin; Praluent, a cholesterol-lowering drug; and Multaq, an anti-arrhythmic drug. Additionally, it offers Plavix for atherothrombotic conditions; Lovenox for the prophylaxis, venous thromboembolism, and acute coronary syndrome; Aprovel and CoAprovel anti-hypertensives; Renagel and Renvela for patients undergoing dialysis; Synvisc and Synvisc-One viscosupplements for osteoarthritis; Stilnox for insomnia; Allegra for seasonal allergic rhinitis and uncomplicated hives; and Depakine for epilepsy. It also provides generic products; and products for allergy, cough, cold, pain, nutrition, digestion, pediatrics, influenza, meningitis, travel, and endemic vaccines; and adult and adolescent boosters. Sanofi has collaborations with Verily Life Sciences LLC; Happify Health; GlaxoSmithKline Plc; Kymera Therapeutics; Parkinson's Foundation, Inc.; and Nurix Therapeutics, Inc. The company was formerly known as Sanofi-Aventis. Sanofi was incorporated in 1994 and is headquartered in Paris, France.",
  "city": "Paris",
  "phone": "33 1 53 77 40 00",
  "country": "France",
  "companyOfficers": [],
  "website": "http://www.sanofi.com",
  "maxAge": 1,
  "address1": "54, Rue La BoEtie",
  "industry": "Drug Manufacturersâ€”General",
  "previousClose": 95.75,
  "regularMarketOpen": 98.2397,
  "twoHundredDayAverage": 100.62863,
  "trailingAnnualDividendYield": 0.03686684,
  "payoutRatio": 0.3559,
  "volume24Hr": null,
  "regularMarketDayHigh": 100.1,
  "navPrice": null,
  "averageDailyVolume10Day": 1112,
  "totalAssets": null,
  "regularMarketPreviousClose": 95.75,
  "fiftyDayAverage": 97.20576,
  "trailingAnnualDividendRate": 3.53,
  "open": 98.2397,
  "averageVolume10days": 1112,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": 3.41,
  "exDividendDate": 1588550400,
  "beta": 0.360572,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 98.2397,
  "priceHint": 2,
  "currency": "USD",
  "trailingPE": 25.654638,
  "regularMarketVolume": 4519,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 123716280320,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 4107,
  "priceToSalesTrailing12Months": null,
  "dayLow": 98.2397,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 4519,
  "fiftyTwoWeekHigh": 108.61,
  "forwardPE": 13.114624,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": 3.89,
  "fiftyTwoWeekLow": 77,
  "bid": 0,
  "tradeable": false,
  "dividendYield": 0.0343,
  "bidSize": 0,
  "dayHigh": 100.1,
  "exchange": "PNK",
  "shortName": "SANOFI",
  "longName": "Sanofi",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": true,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "SNYNF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_687130",
  "uuid": "c1257957-797e-30a5-aad2-5c19818e3282",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0.29809,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": 7.59,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 1256370048,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": 52.498,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1577750400,
  "heldPercentInstitutions": 0.44339,
  "netIncomeToCommon": null,
  "trailingEps": 3.88,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": 1.8960723,
  "heldPercentInsiders": 0.11076,
  "nextFiscalYearEnd": 1640908800,
  "mostRecentQuarter": 1601424000,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 1115292157,
  "enterpriseValue": 124783550464,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": 0.105,
  "dateShortInterest": null,
  "pegRatio": 1.49,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 98.2397,
  "logo_url": "https://logo.clearbit.com/sanofi.com"
}